We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBIN icon
226
Fortune Brands Innovations
FBIN
$6.06B
$606K 0.06%
+11,846
New +$694K
BHF icon
227
Brighthouse Financial
BHF
$3.5B
$601K 0.06%
14,660
-17,357
-54% -$838K
ALLE icon
228
Allegion
ALLE
$14.4B
$598K 0.06%
+6,104
New +$662K
CMCSA icon
229
Comcast
CMCSA
$90B
$598K 0.06%
+15,248
New +$654K
SAGE
230
DELISTED
Sage Therapeutics
SAGE
$595K 0.06%
+18,426
New +$618K
PRLB icon
231
Protolabs
PRLB
$2.13B
$592K 0.06%
12,372
+1,709
+16% +$79.3K
KWR icon
232
Quaker Houghton
KWR
$2.92B
$589K 0.06%
+3,942
New +$610K
ICPT
233
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$589K 0.06%
42,653
– –
COF icon
234
Capital One
COF
$134B
$586K 0.06%
5,624
-353
-6% -$43.2K
VEEV icon
235
Veeva Systems
VEEV
$37.4B
$584K 0.06%
2,949
-3,202
-52% -$589K
DCI icon
236
Donaldson
DCI
$11.4B
$583K 0.06%
12,112
-5,149
-30% -$259K
MKC icon
237
McCormick & Company Non-Voting
MKC
$14.2B
$579K 0.06%
+6,954
New +$659K
EFOR
238
Everforth Inc
EFOR
$1.32B
$578K 0.06%
+6,405
New +$657K
KNDI
239
Kandi Technologies Group
KNDI
$65.5M
$578K 0.06%
240,952
+39,429
+20% +$102K
AL
240
DELISTED
Air Lease Corp
AL
$576K 0.06%
+17,227
New +$653K
VOYA icon
241
Voya Financial
VOYA
$9.19B
$576K 0.06%
9,669
-2,525
-21% -$162K
CNS icon
242
Cohen & Steers
CNS
$4.3B
$575K 0.06%
9,039
-2,920
-24% -$221K
QVCGA
243
DELISTED
QVC Group Inc Series A
QVCGA
$575K 0.06%
+4,005
New +$778K
GAP
244
The Gap Inc
GAP
$7.37B
$574K 0.06%
+69,653
New +$806K
SSNC icon
245
SS&C Technologies
SSNC
$18.6B
$572K 0.06%
+9,845
New +$633K
META icon
246
Meta Platforms (Facebook)
META
$1.51T
$571K 0.06%
3,542
+912
+35% +$176K
PSX icon
247
Phillips 66
PSX
$81.4B
$571K 0.06%
+6,967
New +$645K
JOYY
248
JOYY Inc
JOYY
$3.75B
$571K 0.06%
19,127
+5,790
+43% +$213K
HTT
249
High Templar Tech Ltd
HTT
$391M
$570K 0.06%
518,305
– –
HTLD icon
250
Heartland Express
HTLD
$956M
$566K 0.06%
40,708
-27,623
-40% -$382K
8 9
10
11 12

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.